Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review

  • ID: 4391494
  • SWOT Analysis
  • Region: India
  • 43 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Atul Ltd
  • BASF India Ltd
  • Divi's Laboratories Ltd
  • Hikal Ltd
  • Suven Life Sciences Ltd
  • MORE
Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol. It has premier facilities for the manufacture of APIs, PFIs and FDs. With offices in India, the US, the UK, China and Colombia, the company offers products and solutions to companies across the world. Granules also provides contract research and manufacturing services. Its key clients include leading generic and branded pharmaceutical companies. Granules is headquartered in Hyderabad, Telangana, India.

Granules India Ltd Key Recent Developments

Aug 16,2017: Granules India Reports Establishment Inspection Report (EIR) From US FDA-Reg.
Aug 14,2017: Granules India Reported Its First Quarter Financial Results 2017
Jun 08,2017: Pharmaceutical company to expand in Virginia
Feb 03,2017: Granules India’s Gagillapur facility completed INFARMED reinspection
Jan 06,2017: Granules India’s Gagillapur Facility Completed INFARMED Inspection

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Atul Ltd
  • BASF India Ltd
  • Divi's Laboratories Ltd
  • Hikal Ltd
  • Suven Life Sciences Ltd
  • MORE
Section 1 - About the Company
  • Granules India Ltd - Key Facts
  • Granules India Ltd - Key Employees
  • Granules India Ltd - Key Employee Biographies
  • Granules India Ltd - Major Products and Services
  • Granules India Ltd - History
  • Granules India Ltd - Company Statement
  • Granules India Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Granules India Ltd - Business Description
  • Granules India Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Granules India Ltd - Strengths
  • Granules India Ltd - Weaknesses
  • Granules India Ltd - Opportunities
  • Granules India Ltd - Threats
  • Granules India Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Granules India Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 16, 2017: Granules India Reports Establishment Inspection Report (EIR) From US FDA-Reg.
  • Aug 14, 2017: Granules India Reported Its First Quarter Financial Results 2017
  • Feb 03, 2017: Granules India’s Gagillapur facility completed INFARMED reinspection
  • Jan 06, 2017: Granules India’s Gagillapur Facility Completed INFARMED Inspection
  • Jan 04, 2017: Granules India Announces Appointment of Dr. V.V.N.K.V. Prasada Raju as an Additional Director
  • Dec 19, 2016: Granules India Provides Update On Granules OmniChem Facility
  • Oct 17, 2016: Granules India’s Gagillapur facility successfully completed US FDA inspection
  • May 30, 2016: Granules India’s Jeedimetla plant received Establishment Inspection Report from the US FDA
  • Apr 28, 2016: Granules India : Revenue increases 11% to Rs. 1,431 Cr.; Net Profit surges 30% to Rs. 118 Cr
  • Jan 28, 2016: Granules India : Revenue increases 8% to Rs. 345 Cr.; Net Profit surges 15% to Rs. 27 Cr
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Granules India Ltd, Key Facts
  • Granules India Ltd, Key Employees
  • Granules India Ltd, Key Employee Biographies
  • Granules India Ltd, Major Products and Services
  • Granules India Ltd, History
  • Granules India Ltd, Subsidiaries
  • Granules India Ltd, Joint Venture
  • Granules India Ltd, Key Competitors
  • Granules India Ltd, Ratios based on current share price
  • Granules India Ltd, Annual Ratios
  • Granules India Ltd, Annual Ratios (Cont...1)
  • Granules India Ltd, Annual Ratios (Cont...2)
  • Granules India Ltd, Interim Ratios
  • Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Granules India Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Granules India Ltd, Performance Chart (2013 - 2017)
  • Granules India Ltd, Ratio Charts
  • Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Granules India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceutical Industries Ltd
  • Suven Life Sciences Ltd
  • Ind-Swift Laboratories Ltd
  • Hikal Ltd
  • Divi's Laboratories Ltd
  • BASF India Ltd
  • Atul Ltd
  • Aditya Birla Chemicals (India) Limited
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll